Pfizer, Inc. · NYSE:PFE
Pfizer — First Fridays Webinar Series: Medical Education Group (MEG) (January 2011)
20 slides from Pfizer's conference presentation, Jan 7, 2011
Slide 1: First Fridays Webinar Series: It's All About the Patient
First Fridays Webinar Series: Medical Education Group (MEG) It’s All About the Patient January 7, 2011 Freda Lewis-Hall, EVP and CMO Freda Lewis-Hall, M.D. is Executive Vice President and Chief Medical Officer for Pfizer Inc Inc. She leads Pfizer Medical, the division charged with regulatory and saf
Slide 2: Maureen Doyle-Scharff, Senior Director, Team Lead
Maureen Doyle-Scharff, Senior Director, Team Lead Maureen Doyle-Scharff, MBA, FACME Senior Director, Team Lead, Medical Education Group at Pfizer. Sh has She h worked k d in i th the field fi ld off medical education for nearly 20 years. Maureen currently serves on the Board of Directors for the All
Slide 3: Agenda: It's All About the Patient and Today's Objectives
Agenda: It’s All About the Patient • Welcome – Freda Lewis-Hall, MD, Chief Medical Officer • Recap p of 2010 – Maureen Doyley Scharff,, MBA,, FACME, Senior Director • It’s All About the Patient – Betsy Woodall, PharmD, MBA, Director • Achieving Patient-Level Data – You Can Do It!, Pam McFadden, AVP
Slide 4: It's All About the Patient (P.A.T.I.E.N.T.)
It’s All About the Patient P Patients are in the forefront of our operation A Addressing performance improvement T Totally-engaged learners I Interdisciplinary care for a holistic approach E Education is an intermediate step to improved patient care N Needs assessment T Tools to get there It’s All A
Slide 5: Why East Texas?
Improving Community H lth in Health i East E t Texas T Pam McFadden Andrew Crim Why East Texas? • High concentration of potentially preventable hospitalizations due to COPD • Convergence of multiple risk factors • Existing relationships, relationships knowledge of region and target audience Departme
Slide 6: About East Texas and How Project Started
About East Texas • Approximates the combined land area of VT, NH, MA, RI and CT, CT or roughly twice the size of New Jersey Jersey. • 50-county region with 2.2 million people • 1800 primary care physicians, NPs and PAs (MUA) • Higher smoking rates than the state or US • 20% population below poverty
Slide 7: What we found and Overall Objectives
What we found • Contributing Factors CME • Contributing Factors CME Couldn’t Influence Could Influence • Patient Demographics • Poor rates of spirometry & poor interpretation of • Increasingly Older results • Increasingly Minority • High rates of Mis- & under- • Occupational Hazards diagnosis • Smok
Slide 8: Activity Design and Planned Outcomes
Activity Design • Small Small‐group group dialogues in the “worst worst of the worst” counties in East Texas Primary Strategy (<20/activity) • A small sub‐grant to a public health department or Area Health Education Center to serve as educational resources for local clinicians Reinforcing • Follow‐u
Slide 9: Participation: Did It Work?
Participation Activity Participation 244 69% Physician Live activities 9 % NP 11% PA 11% Other 321 Certificates 54% Physician Enduring Cases 19% NP 25% PA 2% Other 103 81% Physician AHEC Sub Grant 4% PA (Live, hands-on Spirometry Workshop) 10% Nurse (NPs, RNs, LVNs) 5% Other DID IT WORK? Activities
Slide 10: Level 4: Competence
LEVEL 4: COMPETENCE Confidence in accurately interpreting spirometry results Following the activity, 68% of participants were highly confident or confident in their ability to interpret spirometry results, an increase of 27% from pre-activity results from the same participants. Those who indicated h
Slide 11: Confidence in ability to aggressively treat and slow progression of COPD
Confidence in ability to aggressively treat and slow progression of COPD Following the activity, 76% of participants were highly confident or confident in their ability to ability to aggressively treat and slow the progression of COPD, an increase of 11% from pre-activity results from the same parti
Slide 12: Level 5: Performance, Level 6: Patient Health
Areas where 100% of participants indicated an intent to increase their efforts in… Screening for COPD using Ascertaining smoking Spirometry status in all patients T workk with To ith other th llocall Patient education physicians and healthcare regarding smoking and providers to eliminate local other
Slide 13: Changes in Practice and Diagnostic Performance
Changes in Practice • Following each activity, activity I did not make any changes to my practice 10% 45-day post surveys were mailed/e-mailed. This activity confirmed my current 30% practices • 46% of participants responded I’ve increased efforts to screen for 30% COPD using spirometry • “What have
Slide 14: Treatment Performance/Patient Health; Level 7: Community Health
Treatment Performance/Patient Health Pre-Activity Post-Activity • Increase in prescriptions commonly used for COPD noted in the quarter following the activity in the targeted counties • The absence of significant correlation between the slight increase of COPD diagnosis and the significant increase
Slide 15: How Was Impact on Community Health Assessed?
How Was Impact on Community Health Assessed? • Potentially preventable hospitalizations • Data collected by the Department of State Health Services • HEDIS data set reported by each hospital • COPD is one set tracked by state How do Preventable Hospitalizations relate to Community Health? • From 200
Slide 16: Preventable Hospitalizations Related to COPD
Preventable Hospitalizations Related to COPD • Between 2005-2008, COPD accounted for 109 581 hhospitalizations 109,581 it li ti • Average hospital charge was $25,203 • Total hospital charges were $2.7 $2 7 billion, billion or $157 for each Texan Source: Center for Health Statistics, Texas Department
Slide 17: Admission Rates/100,000
Admission Rates/100,000 County q1rate08 q2rate08 q3rate08 q4rate08 q1rate09 q2rate09 q3rate09 Kaufman 123.64 103.26 78.80 101.90 114.78 80.48 64.65 Angelina 137.81 49.22 39.38 90.23 112.05 55.22 58.46 Trinity 273.59 255.94 132.38 229.46 307.23 149.23 87.78 Franklin 253.96 229.77 133.03 120.93 120.67
Slide 18: County to County Comparison; In Real Numbers
County to County Comparison • Identified 10 counties in East Texas with similar demographics population as control demographics, • Clinicians in control received mailed follow-up cases • Averaged admission rates in same quarters as target counties to assess pre/post change immediately following CME
Slide 19: Summary
Summary • Higher level outcomes can be measured • In many cases, data already exists to make your job easier • It may take a while – last activity was held mid-2008 • Used solid educational design focusing on local needs • Know your audience • The success of this CME initiative is replicable in dise
Slide 20: Until Next Time…
Until Next Time… • Please join us for our next webinar – A Continuation of It’s All About the Patient: Friday February 4th, 2011 – Friday, – 11am ET • Submit your grant requests – window closes January 15th, 2011 20
Pfizer — First Fridays Webinar Series: Medical Education Group (MEG) (January 2011) on 6ix